Nutrigenomics for the prevention and treatment diabetes

[1] Aggarwal B.B.: Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu. Rev. Nutr., 2010; 30: 173–199 AggarwalB.B. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals Annu. Rev. Nutr. 2010 30 173 199 10.1146/annurev.nutr.012809.104755314415620420526 Search in Google Scholar

[2] American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care, 2014; 37: S81–S90 American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 2014 37 S81 S90 10.2337/dc14-S08124357215 Search in Google Scholar

[3] Babu P.V., Liu D., Gilbert E.R.: Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J. Nutr. Biochem., 2013; 24: 1777–1789 BabuP.V. LiuD. GilbertE.R. Recent advances in understanding the anti-diabetic actions of dietary flavonoids J. Nutr. Biochem. 2013 24 1777 1789 10.1016/j.jnutbio.2013.06.003382197724029069 Search in Google Scholar

[4] Cai E.P., Lin J.K.: Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic β cells. J. Agric. Food Chem., 2009; 57: 9817–9827 CaiE.P. LinJ.K. Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic β cells J. Agric. Food Chem. 2009 57 9817 9827 10.1021/jf902618v19803520 Search in Google Scholar

[5] Carneiro E.M., Latorraca M.Q., Araujo E., Beltrá M., Oliveras M.J., Navarro M., Berná G., Bedoya F.J., Velloso L.A., Soria B., Martin F.: Taurine supplementation modulates glucose homeostasis and islet function. J. Nutr. Biochem., 2009; 20: 503–511 CarneiroE.M. LatorracaM.Q. AraujoE. BeltráM. OliverasM.J. NavarroM. BernáG. BedoyaF.J. VellosoL.A. SoriaB. MartinF. Taurine supplementation modulates glucose homeostasis and islet function J. Nutr. Biochem. 2009 20 503 511 10.1016/j.jnutbio.2008.05.00818708284 Search in Google Scholar

[6] Castellano J.M., Guinda A., Delgado T., Rada M., Cayuela J.A.: Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes. Diabetes, 2013; 62: 1791–1799 CastellanoJ.M. GuindaA. DelgadoT. RadaM. CayuelaJ.A. Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes Diabetes 2013 62 1791 1799 10.2337/db12-1215366162523704520 Search in Google Scholar

[7] Castro M.C., Francini F., Gagliardino J.J., Massa M.L.: Lipoic acid prevents fructose-induced changes in liver carbohydrate metabolism: Role of oxidative stress. Biochim. Biophys. Acta, 2014; 1840: 1145–1151 CastroM.C. FranciniF. GagliardinoJ.J. MassaM.L. Lipoic acid prevents fructose-induced changes in liver carbohydrate metabolism: Role of oxidative stress Biochim. Biophys. Acta 2014 1840 1145 1151 10.1016/j.bbagen.2013.12.00524361606 Search in Google Scholar

[8] Cobianchi L., Fornoni A., Pileggi A., Molano R.D., Sanabria N.Y., Gonzalez-Quintana J., Bocca N., Marzorati S., Zahr E., Hogan A.R., Ricordi C., Inverardi L.: Riboflavin inhibits IL-6 expression and p38 activation in islet cells. Cell Transplant., 2008; 17: 559–566 CobianchiL. FornoniA. PileggiA. MolanoR.D. SanabriaN.Y. Gonzalez-QuintanaJ. BoccaN. MarzoratiS. ZahrE. HoganA.R. RicordiC. InverardiL. Riboflavin inhibits IL-6 expression and p38 activation in islet cells Cell Transplant. 2008 17 559 566 10.3727/09636890878509606018714675 Search in Google Scholar

[9] Corless M., Kiely A., McClenaghan N.H., Flatt P.R., Newsholme P.: Glutamine regulates expression of key transcription factor, signal transduction, metabolic gene, and protein expression in a clonal pancreatic β-cell line. J. Endocrinol., 2006; 190: 719–727 CorlessM. KielyA. McClenaghanN.H. FlattP.R. NewsholmeP. Glutamine regulates expression of key transcription factor, signal transduction, metabolic gene, and protein expression in a clonal pancreatic β-cell line J. Endocrinol. 2006 190 719 727 10.1677/joe.1.0689217003273 Search in Google Scholar

[10] Definicja, rozpoznawanie i klasyfikacja cukrzycy Raport Grupy Konsultacyjnej WHO (1999). Medycyna Praktyczna 2000/01. https://www.mp.pl/artykuly/1161,definicja-rozpoznawanie-i-klasyfikacjacukrzycyraport-grupy-konsultacyjnej-who-1999 (18.04.2020) Definicja, rozpoznawanie i klasyfikacja cukrzycy Raport Grupy Konsultacyjnej WHO 1999 Medycyna Praktyczna 2000/01 https://www.mp.pl/artykuly/1161,definicja-rozpoznawanie-i-klasyfikacjacukrzycyraport-grupy-konsultacyjnej-who-1999 (18.04.2020) Search in Google Scholar

[11] Diaz-Gerevini G.T., Repossi G., Dain A., Tarres M.C., Das U.N., Eynard A.R.: Beneficial action of resveratrol: How and why? Nutrition, 2016; 32: 174–178 Diaz-GereviniG.T. RepossiG. DainA. TarresM.C. DasU.N. EynardA.R. Beneficial action of resveratrol: How and why? Nutrition 2016 32 174 178 10.1016/j.nut.2015.08.01726706021 Search in Google Scholar

[12] Dong H., Wang N., Zhao L., Lu F.: Berberine in the treatment of type 2 diabetes mellitus: A systemic review and meta-analysis. Evid. Based Complement. Alternat. Med., 2012; 2012: 591654 DongH. WangN. ZhaoL. LuF. Berberine in the treatment of type 2 diabetes mellitus: A systemic review and meta-analysis Evid. Based Complement. Alternat. Med. 2012 2012 591654 10.1155/2012/591654347887423118793 Search in Google Scholar

[13] Fenech M., El-Sohemy A., Cahill L., Ferguson L.R., French T.A.C., Tai E.S., Milner J., Koh W.P., Xie L., Zucker M., Buckley M., Cosgrove L., Lockett T., Fung K.Y., Head R.: Nutrigenetics and nutrigenomics: Viewpoints on the current status and applications in nutrition research and practice. J. Nutrigenet. Nutrigenomics, 2011; 4: 69–89 FenechM. El-SohemyA. CahillL. FergusonL.R. FrenchT.A.C. TaiE.S. MilnerJ. KohW.P. XieL. ZuckerM. BuckleyM. CosgroveL. LockettT. FungK.Y. HeadR. Nutrigenetics and nutrigenomics: Viewpoints on the current status and applications in nutrition research and practice J. Nutrigenet. Nutrigenomics 2011 4 69 89 10.1159/000327772312154621625170 Search in Google Scholar

[14] Fowler M.J.: Leczenie cukrzycy: Doustne leki przeciwcukrzycowe. Diabetol. Dypl., 2010; 7: 30–33 FowlerM.J. Leczenie cukrzycy: Doustne leki przeciwcukrzycowe Diabetol. Dypl. 2010 7 30 33 Search in Google Scholar

[15] Fu Z., Zhang W., Zhen W., Lum H., Nadler J., Bassaganya-Riera J., Jia Z., Wang Y., Misra H., Liu D.: Genistein induces pancreatic β-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice. Endocrinology, 2010; 151: 3026–3037 FuZ. ZhangW. ZhenW. LumH. NadlerJ. Bassaganya-RieraJ. JiaZ. WangY. MisraH. LiuD. Genistein induces pancreatic β-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice Endocrinology 2010 151 3026 3037 10.1210/en.2009-1294290394220484465 Search in Google Scholar

[16] Gijsbers L., Ding E.L., Malik V.S., de Goede J., Geleijnse J.M., Soedamah-Muthu S.S.: Consumption of dairy foods and diabetes incidence: A dose-response meta-analysis of observational studies. Am. J. Clin. Nutr. 2016; 103: 1111–1124 GijsbersL. DingE.L. MalikV.S. de GoedeJ. GeleijnseJ.M. Soedamah-MuthuS.S. Consumption of dairy foods and diabetes incidence: A dose-response meta-analysis of observational studies Am. J. Clin. Nutr 2016 103 1111 1124 10.3945/ajcn.115.12321626912494 Search in Google Scholar

[17] GUS. Infografika – Światowy Dzień Walki z Cukrzycą (14 listopada). https://stat.gov.pl/download/gfx/portalinformacyjny/pl/defaultaktualnosci/5866/46/3/1/cukrzyca_2018-01.jpg (15.04.2020) GUS Infografika – Światowy Dzień Walki z Cukrzycą (14 listopada) https://stat.gov.pl/download/gfx/portalinformacyjny/pl/defaultaktualnosci/5866/46/3/1/cukrzyca_2018-01.jpg (15.04.2020) Search in Google Scholar

[18] Hagman D.K., Hays L.B., Parazzoli S.D., Poitout V.: Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans. J. Biol. Chem., 2005; 280: 32413–32418 HagmanD.K. HaysL.B. ParazzoliS.D. PoitoutV. Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans J. Biol. Chem. 2005 280 32413 32418 10.1074/jbc.M506000200136126715944145 Search in Google Scholar

[19] Hall E., Dayeh T., Kirkpatrick C.L., Wollheim C.B., Dekker Nitert M., Ling C.: DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic islets. BMC Med. Genet., 2013; 14: 76 HallE. DayehT. KirkpatrickC.L. WollheimC.B. Dekker NitertM. LingC. DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic islets BMC Med. Genet. 2013 14 76 10.1186/1471-2350-14-76372796023879380 Search in Google Scholar

[20] Hindorff L.A., MacArthur J., Morales J., Junkins H.A., Hall P.N., Klemm A.K., Manolio T.A.: A Catalog of Published Genome-Wide Association Studies. http://www.genome.gov/gwastudies (20.04.2020) HindorffL.A. MacArthurJ. MoralesJ. JunkinsH.A. HallP.N. KlemmA.K. ManolioT.A. A Catalog of Published Genome-Wide Association Studies http://www.genome.gov/gwastudies (20.04.2020) Search in Google Scholar

[21] Kobori M., Masumoto S., Akimoto Y., Takahashi Y.: Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol. Nutr. Food Res., 2009; 53: 859–868 KoboriM. MasumotoS. AkimotoY. TakahashiY. Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice Mol. Nutr. Food Res. 2009 53 859 868 10.1002/mnfr.20080031019496084 Search in Google Scholar

[22] Kozek E.: Insulin resistance and hyperinsulinemia – clinical aspects. Przegl. Lek., 1996; 53: 647–652 KozekE. Insulin resistance and hyperinsulinemia – clinical aspects Przegl. Lek. 1996 53 647 652 Search in Google Scholar

[23] Lazo de la Vega-Monroy M.L., Larrieta E., German M.S., Baez-Saldana A., Fernandez-Mejia C.: Effects of biotin supplementation in the diet on insulin secretion, islet gene expression, glucose homeostasis and beta-cell proportion. J. Nutr. Biochem., 2013; 24: 169–177 Lazo de la Vega-MonroyM.L. LarrietaE. GermanM.S. Baez-SaldanaA. Fernandez-MejiaC. Effects of biotin supplementation in the diet on insulin secretion, islet gene expression, glucose homeostasis and beta-cell proportion J. Nutr. Biochem. 2013 24 169 177 10.1016/j.jnutbio.2012.03.02022841397 Search in Google Scholar

[24] Lewicki S., Lewicka A., Kalicki B., Sobolewska-Ruta A., Debski B., Zdanowski R., Syryło T., Kloc M., Kubiak J.Z.: Effects of genistein on insulin pathway-related genes in mouse differentiated myoblast C2C12 cell line: Evidence for two independent modes of action. Folia Histochem. Cytobiol., 2018; 56: 123–132 LewickiS. LewickaA. KalickiB. Sobolewska-RutaA. DebskiB. ZdanowskiR. SyryłoT. KlocM. KubiakJ.Z. Effects of genistein on insulin pathway-related genes in mouse differentiated myoblast C2C12 cell line: Evidence for two independent modes of action Folia Histochem. Cytobiol. 2018 56 123 132 10.5603/FHC.a2018.001429998457 Search in Google Scholar

[25] Lovis P., Roggli E., Laybutt D.R., Gattesco S., Yang J.Y., Widmann C., Abderrahmani A., Regazzi R.: Alterations in microRNA expression contribute to fatty acid-induced pancreatic β-cell dysfunction. Diabetes, 2008; 57: 2728–2736 LovisP. RoggliE. LaybuttD.R. GattescoS. YangJ.Y. WidmannC. AbderrahmaniA. RegazziR. Alterations in microRNA expression contribute to fatty acid-induced pancreatic β-cell dysfunction Diabetes 2008 57 2728 2736 10.2337/db07-1252255168318633110 Search in Google Scholar

[26] Mancini A., Imperlini E., Nigro E., Montagnese C., Daniele A., Orrù S., Buono P.: Biological and nutritional properties of palm oil and palmitic acid: Effects on health. Molecules, 2015; 20: 17339–17361 ManciniA. ImperliniE. NigroE. MontagneseC. DanieleA. OrrùS. BuonoP. Biological and nutritional properties of palm oil and palmitic acid: Effects on health Molecules 2015 20 17339 17361 10.3390/molecules200917339633178826393565 Search in Google Scholar

[27] Miller R.G., Secrest A.M., Sharma R.K., Songer T.J., Orchard T.J.: Improvements in the life expectancy of type 1 diabetes: The Pittsburgh Epidemiology of Diabetes Complications study cohort. Diabetes, 2012; 61: 2987–2992 MillerR.G. SecrestA.M. SharmaR.K. SongerT.J. OrchardT.J. Improvements in the life expectancy of type 1 diabetes: The Pittsburgh Epidemiology of Diabetes Complications study cohort Diabetes 2012 61 2987 2992 10.2337/db11-1625347855122851572 Search in Google Scholar

[28] Mosley A.L., Corbett J.A., Ozcan S.: Glucose regulation of insulin gene expression requires the recruitment of p300 by the β-cell-specific transcription factor Pdx-1. Mol. Endocrinol., 2004; 18: 2279–2290 MosleyA.L. CorbettJ.A. OzcanS. Glucose regulation of insulin gene expression requires the recruitment of p300 by the β-cell-specific transcription factor Pdx-1 Mol. Endocrinol. 2004 18 2279 2290 10.1210/me.2003-046315166251 Search in Google Scholar

[29] Patrick C., Wang G.S., Lefebvre D.E., Crookshank J.A., Sonier B., Eberhard C., Mojibian M., Kennedy C.R., Brooks S.P., Kalmokoff M.L., Maglio M., Troncone R., Poussier P., Scott F.W.: Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance, and altered cathelicidin antimicrobial peptide. Diabetes, 2013; 62: 2036–2047 PatrickC. WangG.S. LefebvreD.E. CrookshankJ.A. SonierB. EberhardC. MojibianM. KennedyC.R. BrooksS.P. KalmokoffM.L. MaglioM. TronconeR. PoussierP. ScottF.W. Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance, and altered cathelicidin antimicrobial peptide Diabetes 2013 62 2036 2047 10.2337/db12-1243366160323349499 Search in Google Scholar

[30] Phillips C.M.: Nutrigenetics and metabolic disease: Current status and implications for personalised nutrition. Nutrients, 2013; 5: 32–57 PhillipsC.M. Nutrigenetics and metabolic disease: Current status and implications for personalised nutrition Nutrients 2013 5 32 57 10.1201/b16307-3 Search in Google Scholar

[31] Poitout V., Hagman D., Stein R., Artner I., Robertson R.P., Harmon J.S.: Regulation of the insulin gene by glucose and fatty acids. J. Nutr., 2006; 136: 873–876 PoitoutV. HagmanD. SteinR. ArtnerI. RobertsonR.P. HarmonJ.S. Regulation of the insulin gene by glucose and fatty acids J. Nutr. 2006 136 873 876 10.1093/jn/136.4.873185325916549443 Search in Google Scholar

[32] Poitout V., Robertson R.P.: Glucolipotoxicity: Fuel excess and β-cell dysfunction. Endocr. Rev., 2008; 29: 351–366 PoitoutV. RobertsonR.P. Glucolipotoxicity: Fuel excess and β-cell dysfunction Endocr. Rev. 2008 29 351 366 10.1210/er.2007-0023252885818048763 Search in Google Scholar

[33] Qiu L.; List E.O.; Kopchick J.J.: Differentially expressed proteins in the pancreas of diet-induced diabetic mice. Mol. Cell. Proteomics, 2005; 4: 1311–1318 QiuL. ListE.O. KopchickJ.J. Differentially expressed proteins in the pancreas of diet-induced diabetic mice Mol. Cell. Proteomics 2005 4 1311 1318 10.1074/mcp.M500016-MCP20015961380 Search in Google Scholar

[34] Rojas A., Carrasco M., Delgado I., Cobo N., Tejedo J.R., Bedoya F.J., Gauthier B., Soria B., Martín F.: Signaling pathways and transcription factors involved in pancreatic islet development. In: Islam S., editor. Adv. Exp. Med. Biol.: The Islets of Langerhans 2. Springer; Berlin, Germany, 2014; 109–128 RojasA. CarrascoM. DelgadoI. CoboN. TejedoJ.R. BedoyaF.J. GauthierB. SoriaB. MartínF. Signaling pathways and transcription factors involved in pancreatic islet development In: IslamS. editor. Adv. Exp. Med. Biol.: The Islets of Langerhans 2 Springer Berlin, Germany 2014 109 128 Search in Google Scholar

[35] Różańska D., Regulska-Ilow A.: The significance of anthocyanins in the prevention and treatment of type 2 diabetes. Adv. Clin. Exp. Med., 2018; 27: 135–142 RóżańskaD. Regulska-IlowA. The significance of anthocyanins in the prevention and treatment of type 2 diabetes Adv. Clin. Exp. Med. 2018 27 135 142 10.17219/acem/6498329521054 Search in Google Scholar

[36] Sakaguchi S., Ono M., Setoguchi R., Yagi H., Hori S., Fehervari Z., Shimizu J., Takahashi T., Nomura T.: Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev., 2006; 212: 8–27 SakaguchiS. OnoM. SetoguchiR. YagiH. HoriS. FehervariZ. ShimizuJ. TakahashiT. NomuraT. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease Immunol. Rev. 2006 212 8 27 10.1111/j.0105-2896.2006.00427.x16903903 Search in Google Scholar

[37] Sales N.M., Pelegrini P.B., Goersch M.C.: Nutrigenomics: Definitions and advances of this new science. J. Nutr. Metab., 2014; 2014: 202759 SalesN.M. PelegriniP.B. GoerschM.C. Nutrigenomics: Definitions and advances of this new science J. Nutr. Metab. 2014 2014 202759 10.1155/2014/202759398486024795820 Search in Google Scholar

[38] Salmond R.J., Filby A., Qureshi I., Caserta S., Zamoyska R.: T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol. Rev., 2009; 228: 9–22 SalmondR.J. FilbyA. QureshiI. CasertaS. ZamoyskaR. T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance Immunol. Rev. 2009 228 9 22 10.1111/j.1600-065X.2008.00745.x19290918 Search in Google Scholar

[39] Sommese L., Zullo A., Mancini F.P., Fabbricini R., Soricelli A., Napoli C.: Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus. Epigenetics, 2017; 12: 401–415 SommeseL. ZulloA. ManciniF.P. FabbriciniR. SoricelliA. NapoliC. Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus Epigenetics 2017 12 401 415 10.1080/15592294.2016.1278097550121128059593 Search in Google Scholar

[40] Temelkova-Kurktschiev T., Stefanov T.: Life style and genetics in obesity and type 2 diabetes. Exp. Clin. Endocrinol. Diabetes, 2012; 120: 1–6 Temelkova-KurktschievT. StefanovT. Life style and genetics in obesity and type 2 diabetes Exp. Clin. Endocrinol. Diabetes 2012 120 1 6 10.1055/s-0031-128583221915815 Search in Google Scholar

[41] Udupa A., Nahar P., Shah S., Kshirsagar M., Ghongane B.: A comparative study of effects of omega-3 fatty acids, alpha lipoic acid and vitamin E in type 2 diabetes mellitus. Ann. Med. Health Sci. Res., 2013; 3: 442–446 UdupaA. NaharP. ShahS. KshirsagarM. GhonganeB. A comparative study of effects of omega-3 fatty acids, alpha lipoic acid and vitamin E in type 2 diabetes mellitus Ann. Med. Health Sci. Res. 2013 3 442 446 10.4103/2141-9248.117954379345624116330 Search in Google Scholar

[42] Vallianou N.G., Evangelopoulos A., Kazazis C.: Resveratrol and diabetes. Rev. Diabet. Stud., 2013; 10: 236–242 VallianouN.G. EvangelopoulosA. KazazisC. Resveratrol and diabetes Rev. Diabet. Stud. 2013 10 236 242 10.1900/RDS.2013.10.236416001024841877 Search in Google Scholar

[43] Wedick N.M., Pan A., Cassidy A., Rimm E.B., Sampson L., Rosner B., Willett W., Hu F.B., Sun Q., van Dam R.M.: Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am. J. Clin. Nutr., 2012; 95: 925–933 WedickN.M. PanA. CassidyA. RimmE.B. SampsonL. RosnerB. WillettW. HuF.B. SunQ. van DamR.M. Dietary flavonoid intakes and risk of type 2 diabetes in US men and women Am. J. Clin. Nutr. 2012 95 925 933 10.4016/39918.01 Search in Google Scholar

[44] Witkowski M., Tabaraie T., Steffens D., Friebel J., Dörner A., Skurk C., Witkowski M., Stratmann B., Tschoepe D., Landmesser U., Rauch U.: MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes. Cardiovasc. Diabetol., 2018; 17: 34 WitkowskiM. TabaraieT. SteffensD. FriebelJ. DörnerA. SkurkC. WitkowskiM. StratmannB. TschoepeD. LandmesserU. RauchU. MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes Cardiovasc. Diabetol. 2018 17 34 10.1186/s12933-018-0678-z638922229477147 Search in Google Scholar

[45] Wolden-Kirk H., Rondas D., Bugliani M., Korf H., Van Lommel L., Brusgaard K., Christesen H.T., Schuit F., Proost P., Masini M., Marchetti P., Eizirik D.L., Overbergh L., Mathieu C.: Discovery of molecular pathways mediating 1,25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and male mouse islets of Langerhans. Endocrinology, 2014; 155: 736–747 Wolden-KirkH. RondasD. BuglianiM. KorfH. Van LommelL. BrusgaardK. ChristesenH.T. SchuitF. ProostP. MasiniM. MarchettiP. EizirikD.L. OverberghL. MathieuC. Discovery of molecular pathways mediating 1,25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and male mouse islets of Langerhans Endocrinology 2014 155 736 747 10.1210/en.2013-140924424042 Search in Google Scholar

[46] World Health Organisation: Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO/IDF Consultation. Geneva, Switzerland, World Health Organisation, 2006. https://www.who.int/diabetes/publications/diagnosis_diabetes2006/en/ (15.04.2020) World Health Organisation: Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia Report of a WHO/IDF Consultation Geneva, Switzerland World Health Organisation 2006 https://www.who.int/diabetes/publications/diagnosis_diabetes2006/en/ (15.04.2020) Search in Google Scholar

[47] World Health Organization: Global Report on Diabetes. Geneva 2016. https://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf (15.04.2020) World Health Organization Global Report on Diabetes Geneva 2016 https://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf (15.04.2020) Search in Google Scholar

[48] Xu G., Kwon G., Cruz W.S., Marshall C.A., McDaniel M.L.: Metabolic regulation by leucine of translation initiation through the mTOR signaling pathway by pancreatic β-cells. Diabetes, 2001; 50: 353–360 XuG. KwonG. CruzW.S. MarshallC.A. McDanielM.L. Metabolic regulation by leucine of translation initiation through the mTOR signaling pathway by pancreatic β-cells Diabetes 2001 50 353 360 10.2337/diabetes.50.2.35311272147 Search in Google Scholar

[49] Yang B.T., Dayeh T.A., Kirkpatrick C.L., Taneera J., Kumar R., Groop L., Wollheim C.B., Nitert M.D., Ling C.: Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets. Diabetologia, 2011; 54: 360–367 YangB.T. DayehT.A. KirkpatrickC.L. TaneeraJ. KumarR. GroopL. WollheimC.B. NitertM.D. LingC. Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets Diabetologia 2011 54 360 367 10.1007/s00125-010-1967-6301731321104225 Search in Google Scholar

[50] Yang B.T., Dayeh T.A., Volkov P.A., Kirkpatrick C.L., Malmgren S., Jing X., Renström E., Wollheim C.B., Nitert M.D., Ling C.: Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes. Mol. Endocrinol., 2012; 26: 1203–1212 YangB.T. DayehT.A. VolkovP.A. KirkpatrickC.L. MalmgrenS. JingX. RenströmE. WollheimC.B. NitertM.D. LingC. Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes Mol. Endocrinol. 2012 26 1203 1212 10.1210/me.2012-1004541699822570331 Search in Google Scholar

[51] Ye D.Z., Tai M.H., Linning K.D., Szabo C., Olson L.K.: MafA expression and insulin promoter activity are induced by nicotinamide and related compounds in INS-1 pancreatic β-cells. Diabetes, 2006; 55: 742–750 YeD.Z. TaiM.H. LinningK.D. SzaboC. OlsonL.K. MafA expression and insulin promoter activity are induced by nicotinamide and related compounds in INS-1 pancreatic β-cells Diabetes 2006 55 742 750 10.2337/diabetes.55.03.06.db05-065316505238 Search in Google Scholar

[52] Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., Bergeron R., Kim J.K., Cushman S.W., Cooney G.J., Atcheson B., White M.F., Kraegen E.W., Shulman G.I.: Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem., 2002; 277: 50230–50236 YuC. ChenY. ClineG.W. ZhangD. ZongH. WangY. BergeronR. KimJ.K. CushmanS.W. CooneyG.J. AtchesonB. WhiteM.F. KraegenE.W. ShulmanG.I. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle J. Biol. Chem. 2002 277 50230 50236 10.1074/jbc.M20095820012006582 Search in Google Scholar

[53] Zalecenia PTD: Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę 2016. Stanowisko Polskiego Towarzystwa Diabetologicznego. Diabetol Klin. 2016; 5: Supl. A Zalecenia PTD Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę 2016. Stanowisko Polskiego Towarzystwa Diabetologicznego Diabetol Klin 2016 5 Supl. A Search in Google Scholar

[54] Zanda M., Onengut-Gumuscu S., Walker N., Shtir C., Gallo D., Wallace C., Smyth D., Todd J.A., Hurles M.E., Plagnol V., Rich S.S.: A genome-wide assessment of the role of untagged copy number variants in type 1 diabetes. PLoS Genet., 2014; 10: e1004367 ZandaM. Onengut-GumuscuS. WalkerN. ShtirC. GalloD. WallaceC. SmythD. ToddJ.A. HurlesM.E. PlagnolV. RichS.S. A genome-wide assessment of the role of untagged copy number variants in type 1 diabetes PLoS Genet 2014 10 e1004367 10.1371/journal.pgen.1004367403847024875393 Search in Google Scholar

[55] Zeitler P., Fu J., Tandon N., Nadeau K., Urakami T., Barrett T., Maahs D.: Type 2 diabetes in the child and adolescent. Pediatr. Diabetes, 2014; 15: 26–46 ZeitlerP. FuJ. TandonN. NadeauK. UrakamiT. BarrettT. MaahsD. Type 2 diabetes in the child and adolescent Pediatr. Diabetes 2014 15 26 46 10.1111/pedi.1217925182306 Search in Google Scholar

[56] Zhang Z., Ding Y., Dai X., Wang J., Li Y.: Epigallocatechin-3-gallate protects pro-inflammatory cytokine induced injuries in insulin-producing cells through the mitochondrial pathway. Eur. J. Pharmacol., 2011; 670: 311–316 ZhangZ. DingY. DaiX. WangJ. LiY. Epigallocatechin-3-gallate protects pro-inflammatory cytokine induced injuries in insulin-producing cells through the mitochondrial pathway Eur. J. Pharmacol. 2011 670 311 316 10.1016/j.ejphar.2011.08.03321925162 Search in Google Scholar

[57] Ziegler A.G., Nepom G.T.: Prediction and pathogenesis in type 1 diabetes. Immunity, 2010; 32: 468–478 ZieglerA.G. NepomG.T. Prediction and pathogenesis in type 1 diabetes Immunity 2010 32 468 478 10.1016/j.immuni.2010.03.018286171620412757 Search in Google Scholar